Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
LAS VEGAS, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Today at CES 2026, AMD (NASDAQ: AMD) Chair and CEO Dr. Lisa Su detailed in the show’s opening keynote how the company’s extensive portfolio of AI products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback